Abstract
Eight patients with sickle cell anemia (SS hemoglobin) were found to have decreased plasma levels of prekallikrein compared to normal control subjects or patients with other types of anemia. The prekallikrein levels in the patients with sickle cell anemia were found to decrease further during a sickle cell crisis. These results suggest that components of the kallikrein-kinin system are profoundly affected in patients with sickle cell anemia, and during crises may play a role in the clinical presentation of patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alkjaersig N., Fletcher A., Joist H., Chaplin H., Jr Hemostatic alterations accompanying sickle cell pain crises. J Lab Clin Med. 1976 Sep;88(3):440–449. [PubMed] [Google Scholar]
- Bauer T. W., Moore G. W., Hutchins G. M. The liver in sickle cell disease. A clinicopathologic study of 70 patients. Am J Med. 1980 Dec;69(6):833–837. doi: 10.1016/s0002-9343(80)80008-8. [DOI] [PubMed] [Google Scholar]
- Colman R. W., Mason J. W., Sherry S. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med. 1969 Oct;71(4):763–773. doi: 10.7326/0003-4819-71-4-763. [DOI] [PubMed] [Google Scholar]
- Isichei U. P. Serum protein profile in sickle cell disease. J Clin Pathol. 1979 Feb;32(2):117–121. doi: 10.1136/jcp.32.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller R. L., Webster M. E., Melmon K. L. Interaction of leukocytes and endotoxin with the plasmin and kinin systems. Eur J Pharmacol. 1975 Aug;33(1):53–60. doi: 10.1016/0014-2999(75)90137-5. [DOI] [PubMed] [Google Scholar]
- Richardson S. G., Matthews K. B., Stuart J., Geddes A. M., Wilcox R. M. Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol. 1979 Jan;41(1):95–103. doi: 10.1111/j.1365-2141.1979.tb03685.x. [DOI] [PubMed] [Google Scholar]
- Rickles F. R., O'Leary D. S. Role of coagulation system in pathophysiology of sickle cell disease. Arch Intern Med. 1974 Apr;133(4):635–641. [PubMed] [Google Scholar]
- Saito H., Poon M. C., Vicic W., Goldsmith G. H., Jr, Menitove J. E. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. J Lab Clin Med. 1978 Jul;92(1):84–95. [PubMed] [Google Scholar]
- Talamo R. C., Haber E., Austen K. F. A radioimmunoassay for bradykinin in plasma and synovial fluid. J Lab Clin Med. 1969 Nov;74(5):816–827. [PubMed] [Google Scholar]
- Webster M. E., Guimaraes J. A., Kaplan A. P., Colman R. W., Pierce J. V. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor. Adv Exp Med Biol. 1976;70(00):285–299. doi: 10.1007/978-1-4684-3267-1_35. [DOI] [PubMed] [Google Scholar]
- Wong P., Colman R. W., Talamo R. C., Babior B. M. Kallikrein-bradykinin system in chronic alcoholic liver disease. Ann Intern Med. 1972 Aug;77(2):205–209. doi: 10.7326/0003-4819-77-2-205. [DOI] [PubMed] [Google Scholar]